Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.81 Issue 4 / 2018
  4. Article
Letters to the Editor
Views

Arq. Bras. Oftalmol. 2018; 81 (4): 10.5935/0004-2749.20180070

Total: 1192

Effective dose of bevacizumab for the treatment of retinopathy of prematurity

Alparslan Şahin1; Fatih Mehmet Türkcü2; Muhammed Şahin3

DOI: 10.5935/0004-2749.20180070

1. Department of Ophthalmology, Batman Private Hospital, Batman, Turkey
2. Department of Ophthalmology, Batman Zilan Hospital, Batman, Turkey
3. Department of Ophthalmology, School of Medicine, Dicle University, Diyarbakır, Turkey

Corresponding author

Alparslan Şahin
Batman Private Hospital. Dept. of Ophthalmology
Batman, Turkey
E-mail: [email protected]

Funding: No specific financial support was available for this study

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose


Read in Portuguese XML Print PDF English
Open Access
Share

How to cite this article:

Şahin A, Türkcü FM, Şahin M. A dose eficaz de bevacizumab para o tratamento da retinopatia da prematuridade. Arq. Bras. Oftalmol. 2018;81(4):. 10.5935/0004-2749.20180070
Export citation